Member Info for GingetheWinge

They are expecting between 1 and 2 euros per test profit.

How about the two that were tested side-by-side with AffiDX ? One with 50% sensitivity the other 0%.

He wasn't shouted down, he was told he'd made his point and framed his question and that time was limited.

What utter ******s.

You can compare them with your own finger test which is more accurate than Innova.
Stick your right index finger up your ar$e, leave for 1 minute, remove and sniff.
Smells like Sh$t - negative.
No smell - positive.

The government's preferred test isn't Innova. It was , but that is coming to an end. Wonder whose test will replace them ?

AffiDX is AN sampling, so only just inside the nose instead of a brain tickler. Not difficult or unpleasant to do - perfect for home use. NCYT test has poor SS stats so not really a goer.

Fully funded even without the additional AffiDX revenue which we will be hearing much more about over the next 10-20 working days and which has the potential to exceed £1billion per annum.

Looks like pretty standard stuff to me.

A couple comments. It isn't a simple as considering the mortality rate. The mortality is only low If ICU treatment is available. Whilst it is true that the proportion of infected people who need hospitalisation is low and has been lowered further by vaccination, if infections are allowed to get out of control then that small proportion of millions still threatens NHS capacity and can tip over into many deaths.
The high R value of the Delta variant and selection pressure which is making newer variants even more infectious makes this almost probable without intervention and management.
Vaccination is definitely helping but isn't solving the problem.

How about the Sovereign, gold-standard ?

That’s a false economy. The elderly are now one of the wealthiest sectors of societies with private pensions consistently outperforming salaries for the last few years.

It isn’t 60,000 it’s 20,000. Just monkey nuts trying to stir it.

It means either not both as the stadium capacity has been reduced to ensure social distancing rules can be met. For a return to normal and full capacity both vaccination and testing will be required.

Its not mentioned because its not an issue apart from with a few posters on here.

Yep, looks like the seller might be done.

You wont need to wait for long. Nothing has changed despite the comments from some 'reading between the lines' of yesterdays presentation. Key news flow is imminent and an RNS could land any day that will se the SP double from here. Innova are out of the game in August and between now and then something else will be taking their market.

There is a word for his numbers - it begins with bol and ends with locks. It was stated yesterday that it will be between 1 and 2 euros per test.

They were building before the FDA recall and the whole scandal broke.

There is no concern.
Validating against a specific variant is utterly pointless as the next variant will become dominant by the time it’s done.
What matters is the overall design is of a broad specificity and is unlikely to be affected by mutation. That coupled to the ability to rapidly modify should a new variant start to evade detection makes for a good test.
One just like AffiDX for that matter.